Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia

Clinical trials have demonstrated that novel oral anticoagulants (NOACs) are noninferior to warfarin in preventing nonvalvular atrial fibrillation- (nvAF-) related stroke and systemic embolism. However, in these trials, NOACs initiation was delayed for a variable period after stroke. Herein, we aime...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed H. Alanazy, Taim Muayqil
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Neurology Research International
Online Access:http://dx.doi.org/10.1155/2019/5373250
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items